Upon failure of first-line ADT, should second-line hormonal manipulation without survival benefit data still be used?

Bibliographic Details
Main Authors: Bannakij Lojanapiwat, Masatoshi Eto, Paul Mainwaring
Format: Article
Language:English
Published: Elsevier 2015-12-01
Series:Prostate International
Online Access:http://www.sciencedirect.com/science/article/pii/S2287888215300933
_version_ 1797719167918407680
author Bannakij Lojanapiwat
Masatoshi Eto
Paul Mainwaring
author_facet Bannakij Lojanapiwat
Masatoshi Eto
Paul Mainwaring
author_sort Bannakij Lojanapiwat
collection DOAJ
first_indexed 2024-03-12T09:01:55Z
format Article
id doaj.art-9839226a1e434ea888f63079f016b8c1
institution Directory Open Access Journal
issn 2287-8882
language English
last_indexed 2024-03-12T09:01:55Z
publishDate 2015-12-01
publisher Elsevier
record_format Article
series Prostate International
spelling doaj.art-9839226a1e434ea888f63079f016b8c12023-09-02T15:38:28ZengElsevierProstate International2287-88822015-12-013SS14S1510.1016/j.prnil.2015.10.007Upon failure of first-line ADT, should second-line hormonal manipulation without survival benefit data still be used?Bannakij Lojanapiwat0Masatoshi Eto1Paul Mainwaring2Department of Urology, Chiang Mai University, ThailandDepartment of Urology, Faculty of Life Sciences, Kumamoto University, JapanICON Cancer Centre, Queensland, Australiahttp://www.sciencedirect.com/science/article/pii/S2287888215300933
spellingShingle Bannakij Lojanapiwat
Masatoshi Eto
Paul Mainwaring
Upon failure of first-line ADT, should second-line hormonal manipulation without survival benefit data still be used?
Prostate International
title Upon failure of first-line ADT, should second-line hormonal manipulation without survival benefit data still be used?
title_full Upon failure of first-line ADT, should second-line hormonal manipulation without survival benefit data still be used?
title_fullStr Upon failure of first-line ADT, should second-line hormonal manipulation without survival benefit data still be used?
title_full_unstemmed Upon failure of first-line ADT, should second-line hormonal manipulation without survival benefit data still be used?
title_short Upon failure of first-line ADT, should second-line hormonal manipulation without survival benefit data still be used?
title_sort upon failure of first line adt should second line hormonal manipulation without survival benefit data still be used
url http://www.sciencedirect.com/science/article/pii/S2287888215300933
work_keys_str_mv AT bannakijlojanapiwat uponfailureoffirstlineadtshouldsecondlinehormonalmanipulationwithoutsurvivalbenefitdatastillbeused
AT masatoshieto uponfailureoffirstlineadtshouldsecondlinehormonalmanipulationwithoutsurvivalbenefitdatastillbeused
AT paulmainwaring uponfailureoffirstlineadtshouldsecondlinehormonalmanipulationwithoutsurvivalbenefitdatastillbeused